UTMDHealthcare · Medical Instruments & SuppliesTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 80 of 100 as at 1 Aug 2026 — inside the top quartile.
Consensus tells you what everyone already believes. The model scores Utah Medical Products, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (98): The share price has been relatively steady.
Revisions (25): Analysts have, on balance, been cutting their forecasts.
The rank is the raw material. Whether the rules would actually own Utah Medical Products, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on UTMD, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 37% of US stocks
Cheaper than 21% of US stocks
Cheaper than 48% of US stocks
Cheaper than 41% of US stocks
Higher than 13% of US stocks
Higher than 24% of US stocks
Higher than 75% of US stocks
Higher than 91% of US stocks
Higher than 88% of US stocks
Higher than 61% of US stocks
Higher than 82% of US stocks
Higher than 40% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. UTMD appears on the weeks it earns a place.
Utah Medical Products reported Q2 earnings per share down 10.1% year over year, with quarterly revenues facing pressure from lost customers and slower new business growth.
Why it matters — This signals potential headwinds to UTMD's revenue and earnings momentum, which could affect the company's financial performance and shareholder returns.
As at 1 Aug 2026, Utah Medical Products, Inc. ranks 80 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (98 of 100).
No analyst covering Utah Medical Products, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UTMD are extrapolating price history, which says nothing about the business.
Utah Medical Products, Inc. returned +35.1% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Utah Medical Products Inc. is a company that specializes in manufacturing and distributing a diverse range of medical devices.
The most recent item we track (Zacks Investment Research, 29 July 2026): "Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses". Utah Medical Products reported Q2 earnings per share down 10.1% year over year, with quarterly revenues facing pressure from lost customers and slower new business growth.
Utah Medical Products Inc. is a company that specializes in manufacturing and distributing a diverse range of medical devices. Its core products cater primarily to critical care areas such as neonatal care, obstetrics, gynecology, and general surgery. The company's products include catheters, blood pressure monitoring kits, and specialized devices used in the labor and delivery rooms, which are crucial in providing optimal patient care during childbirth. Utah Medical Products serves a wide variety of healthcare facilities, including hospitals and outpatient clinics, underscoring its integral role in the medical supply chain. Established in 1978 and headquartered in Utah, USA, the company not only meets the needs of the domestic market but also extends its reach internationally. In the financial markets, Utah Medical Products Inc. is recognized for its consistent delivery of high-quality medical products that are essential in everyday healthcare operations, contributing significantly to the industry’s innovation and efficiency. This positions the company as an important player in the medical device sector, with a robust reputation built on reliability and performance.
CEO Mr. Kevin L. Cornwell · 140 employees · United States · https://www.utahmed.com